Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.

Publication Type:

Journal Article

Source:

Cancer research, Volume 69, Issue 5, p.1739-47 (2009)

Keywords:

2009, Amino Acid Transport System y+L, Animals, Cell Differentiation, Center-Authored Paper, Clinical Research Division, DNA (Cytosine-5-)-Methyltransferase, Gene Expression Profiling, Genes, myc, Genetic Engineering, Genomics Core Facility, Human Biology Division, Humans, Male, MICE, Mice, Inbred C57BL, MORPHOGENESIS, Neoplasm Proteins, Peroxiredoxins, prostate, Prostatic Neoplasms, Shared Resources

Abstract:

Studies centered at the intersection of embryogenesis and carcinogenesis have identified striking parallels involving signaling pathways that modulate both developmental and neoplastic processes. In the prostate, reciprocal interactions between epithelium and stroma are known to influence neoplasia and also exert morphogenic effects via the urogenital sinus mesenchyme. In this study, we sought to determine molecular relationships between aspects of normal prostate development and prostate carcinogenesis. We first characterized the gene expression program associated with key points of murine prostate organogenesis spanning the initial in utero induction of prostate budding through maturity. We identified a highly reproducible temporal program of gene expression that partitioned according to the broad developmental stages of prostate induction, branching morphogenesis, and secretory differentiation. Comparisons of gene expression profiles of murine prostate cancers arising in the context of genetically engineered alterations in the Pten tumor suppressor and Myc oncogene identified significant associations between the profile of branching morphogenesis and both cancer models. Further, the expression of genes comprising the branching morphogenesis program, such as PRDX4, SLC43A1, and DNMT3A, was significantly altered in human neoplastic prostate epithelium. These results indicate that components of normal developmental processes are active in prostate neoplasia and provide further rationale for exploiting molecular features of organogenesis to understand cancer phenotypes.